Our academic collaborators’ seminal contributions push the field forward
Our constellation of renowned thinkers and partners
The right collaborators across pharma, biotech and nonprofit
The next generation of scientific leaders in cancer immunotherapy
Stories & Announcements
PICI in the News
Resources for Press
An Immunologist Breaks Down COVID-19
2019 Annual Report
The Parker Institute for Cancer Immunotherapy Awards $2.75 Million to Support Six Early Career Researchers from Leading Research Institutions
Develop breakthrough immune therapies to turn all cancers into curable diseases faster
The driving force behind PICI’s research and operations
Transformative science requires visionary philanthropy
Join us. Change lives.
Bold ideas are required.
Even for researchers at the top of their field – the brightest scientific minds working at the most acclaimed cancer centers in the country – obstacles to progress and success in the current research and treatment system remain. PICI was designed in collaboration with the world’s leading researchers, doctors and cancer centers to remove these barriers and turn cancer research ideas into real-world results.
In a broken system, the best ideas don’t always win.
But, if we let the science lead the way, the solutions will be within our reach.
We work in dynamic partnership with our scientific community. We’ve built a bespoke infrastructure to quickly mobilize discoveries and fortify the process from idea to outcome. In everything we do – whether a promising clinical trial, a new therapeutic product or novel intellectual property (IP), the path from ideation to innovation in the PICI system yields optimum results. Like the gears and gas of a race car, PICI’s infrastructure drives the concept forward with maximum efficiency and speed, all the way to the finish line.
Promising science must reach patients faster. Our legal experts help researchers navigate the patent process – from discovery to commercialization.
Making sense of data is foundational to ushering in breakthroughs. See how our informatics team uses data to drive research forward.
Collaborations are critical to achieving our mission. Discover how our partners help us propel cutting-edge cancer research.
For immunotherapy to succeed, we must advance our knowledge of the immune system’s interaction with cancer. Discover how our research team brings us closer to finding cures.
Multi-center clinical trials are integral to advancing new treatments to cancer patients. Our clinical development team takes on tough cancers at the speed of life.
Data studied in isolation limits its potential. Discover how our BioTrust integrates research to further our knowledge and spark ideas.
For scientists to focus on discovery, their ideas require a steady stream of support. Few options are available: an endowment, finite grants that require relentless fundraising or partnerships with industry in exchange for the licensing of intellectual property. All these options are time-consuming and difficult – none are evergreen. Our model is. At PICI, we’ve built an organizational model where funding and science work together.
Money invested in PICI directly fuels and facilitates discovery. When we’re successful, revenue returns flow back into the PICI system and our research priorities. Every dollar that goes in is supercharged and highly leveraged, ensuring direct and maximum impact on the science and – more importantly, the patients.